NCT02865265

Brief Summary

The association between ultrasound-guided Pecs II block and parasternal block can represent a valid alternative in the management of acute and postoperative pain syndrome after quadrantectomy with or without axillary dissection.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
Last Updated

August 12, 2016

Status Verified

August 1, 2016

Enrollment Period

Same day

First QC Date

August 4, 2016

Last Update Submit

August 9, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain

    Pain has been evaluate with visual analogue scale (VAS) at 24 months after surgery

    Pain was recorded at 24 months after surgery

Secondary Outcomes (3)

  • Neuropathic postoperative disturbances

    Neuropathic postoperative disturbances were recorded at 24 months after surgery

  • Patient satisfaction

    Patient satisfaction was evaluated at 1 day after surgery

  • Woud healing

    Wound healing was assessed at 24 months after surgery

Study Arms (1)

Pecs II and parasternal blocks

Pecs II block was performed at the level of the fourth rib in the fascial plane between the minor pectoral and serratus anterior muscles, and 20 ml of 0.5% levobupivacaine solution were injected. An ultrasound-guided ipsilateral PaB was performed via two separate injections of 4 ml of 0.375% levobupivacaine at the level of the 2nd and 4th intercostal space underneath the external intercostal membrane between the major pectoral and intercostal muscles close to the surface of the 2nd and 4th rib.

Procedure: Pecs II and parasternal blocks

Interventions

Pecs II block was performed at the level of the fourth rib in the fascial plane between the minor pectoral and serratus anterior muscles, and 20 ml of 0.5% levobupivacaine solution were injected. An ultrasound-guided ipsilateral parasternal block was performed via two separate injections of 4 ml of 0.375% levobupivacaine at the level of the 2nd and 4th intercostal space underneath the external intercostal membrane between the major pectoral and intercostal muscles close to the surface of the 2nd and 4th rib.

Pecs II and parasternal blocks

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for quadrantectomy with or without axillary dissection.

You may qualify if:

  • years of age;
  • American Society of Anesthesiologists (ASA) physical status I-III,
  • patients scheduled for quadrantectomy with or without axillary dissection

You may not qualify if:

  • pregnancy;
  • body mass index (BMI) \>35;
  • allergy to local anesthetics;
  • skeletal or muscle abnormalities of the chest wall;
  • presence of primary or secondary neurological diseases;
  • presence of psychiatric diseases;
  • history of chronic pain or neuropathic disorders;
  • history of drug abuse;
  • state of sepsis;
  • infection
  • tumors of the skin on the chest;
  • primary;
  • secondary coagulopathies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr Emiliano Petrucci

Study Record Dates

First Submitted

August 4, 2016

First Posted

August 12, 2016

Study Start

March 1, 2013

Primary Completion

March 1, 2013

Study Completion

December 1, 2015

Last Updated

August 12, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share